EOS IMAGING (EOSI.PA) Fundamental Analysis & Valuation

EPA:EOSI • FR0011191766

Current stock price

2.45
0 (0%)
Last:

This EOSI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EOSI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EOSI has reported negative net income.
EOSI.PA Yearly Net Income VS EBIT VS OCF VS FCFEOSI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -20.29%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EOSI.PA Yearly ROA, ROE, ROICEOSI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 -500 -1K -1.5K -2K -2.5K

1.3 Margins

Industry RankSector Rank
OM -40.25%
PM (TTM) -46.91%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EOSI.PA Yearly Profit, Operating, Gross MarginsEOSI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EOSI.PA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for EOSI has been increased compared to 1 year ago.
  • The debt/assets ratio for EOSI is higher compared to a year ago.
EOSI.PA Yearly Shares OutstandingEOSI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 5M 10M 15M 20M 25M
EOSI.PA Yearly Total Debt VS Total AssetsEOSI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.68, we must say that EOSI is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 66.63 is on the high side and indicates that EOSI has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 66.63
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACCN/A
WACCN/A
EOSI.PA Yearly LT Debt VS Equity VS FCFEOSI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that EOSI should not have too much problems paying its short term obligations.
  • EOSI has a Quick Ratio of 1.37. This is a bad value and indicates that EOSI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.87
EOSI.PA Yearly Current Assets VS Current LiabilitesEOSI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. EOSI.PA Growth Analysis

3.1 Past

  • EOSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.01%, which is quite impressive.
  • Looking at the last year, EOSI shows a quite strong growth in Revenue. The Revenue has grown by 18.63% in the last year.
  • Measured over the past years, EOSI shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)40.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.51%
Revenue 1Y (TTM)18.63%
Revenue growth 3Y-13.71%
Revenue growth 5Y1.78%
Sales Q2Q%-0.28%

3.2 Future

  • Based on estimates for the next years, EOSI will show a very strong growth in Earnings Per Share. The EPS will grow by 106.76% on average per year.
  • EOSI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.51% yearly.
EPS Next Y42.68%
EPS Next 2Y51.21%
EPS Next 3Y180.42%
EPS Next 5Y106.76%
Revenue Next Year69.87%
Revenue Next 2Y45.9%
Revenue Next 3Y45.27%
Revenue Next 5Y40.51%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EOSI.PA Yearly Revenue VS EstimatesEOSI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EOSI.PA Yearly EPS VS EstimatesEOSI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. EOSI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • EOSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EOSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EOSI.PA Price Earnings VS Forward Price EarningsEOSI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -10.78
EOSI.PA Per share dataEOSI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EOSI's earnings are expected to grow with 180.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.21%
EPS Next 3Y180.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EOSI.PA Dividend Analysis

5.1 Amount

  • EOSI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EOSI.PA Fundamentals: All Metrics, Ratios and Statistics

EOS IMAGING

EPA:EOSI (6/2/2021, 7:00:00 PM)

2.45

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.58M
Revenue(TTM)23.83M
Net Income(TTM)-11.18M
Analysts85
Price Target2.53 (3.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.33
P/FCF N/A
P/OCF N/A
P/B 133.59
P/tB N/A
EV/EBITDA -10.78
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.05
BVpS0.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -20.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -40.25%
PM (TTM) -46.91%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 66.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.87
Altman-Z 0.68
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.51%
EPS Next Y42.68%
EPS Next 2Y51.21%
EPS Next 3Y180.42%
EPS Next 5Y106.76%
Revenue 1Y (TTM)18.63%
Revenue growth 3Y-13.71%
Revenue growth 5Y1.78%
Sales Q2Q%-0.28%
Revenue Next Year69.87%
Revenue Next 2Y45.9%
Revenue Next 3Y45.27%
Revenue Next 5Y40.51%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

EOS IMAGING / EOSI.PA Fundamental Analysis FAQ

What is the fundamental rating for EOSI stock?

ChartMill assigns a fundamental rating of 3 / 10 to EOSI.PA.


Can you provide the valuation status for EOS IMAGING?

ChartMill assigns a valuation rating of 0 / 10 to EOS IMAGING (EOSI.PA). This can be considered as Overvalued.


Can you provide the profitability details for EOS IMAGING?

EOS IMAGING (EOSI.PA) has a profitability rating of 1 / 10.


What is the financial health of EOS IMAGING (EOSI.PA) stock?

The financial health rating of EOS IMAGING (EOSI.PA) is 1 / 10.